Rational Advisors’s Abiomed Inc ABMD Stock Holding History

Rational Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13	Closed	-$4K	–	626
2020 Q3	$4K	Buy	+13	New	+$3.75K	﹤0.01%	417

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rational Advisors's ABMD Position: Q4 2020 in Review

Rational Advisors sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 13 shares — an estimated $4K sold.

Rational Advisors first reported a position in ABMD in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

Rational Advisors reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
Rational Advisors sold 13 Abiomed Inc shares in Q4 2020, an estimated $4K.
Rational Advisors first reported a position in Abiomed Inc in Q3 2020 and held it in 1 quarter.
Rational Advisors's Abiomed Inc position peaked at $4K in Q3 2020.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Rational Advisors's 13F filing for Q4 2020, filed 5 Feb 2021.